[US-헬스케어] 05/14 Wall St. Recap
LLYBULL Eli Lilly (LLY) continues to demonstrate a robust long-term growth strategy, balancing its dominant position in the (GLP-1) obesity market with aggressive expansion into oncology. The recent Q1 earnings beat underscores the company’s operational strength, while the strategic $7…